GlassScriptPhysician profile
Jason Michael Bellak
NPI 1407951700
$41,191.41
in general payments reported to CMS, 2019-2025
50 companies · $15K in 2025
The $15K reported for 2025 was more than what 90% of Allergy & Immunology providers received nationally (typical 2025 total: $1,138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,031 · 2020: $2,217 · 2021: $2,548 · 2022: $2,829 · 2023: $4,068 · 2024: $12K · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $20K · Consulting Fee: $9,507 · Travel and Lodging: $775 · Education: $345.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $19,940.70 |
| Consulting Fee | $9,507.27 |
| Travel and Lodging | $774.85 |
| Education | $345.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $6,982.03 | 2019-2025 | Fasenra, Airsupra, Tezspire |
| Genentech USA, INC. | $5,576.67 | 2019-2025 | Xolair |
| Novartis Pharmaceuticals Corporation | $4,334.56 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $3,274.90 | 2019-2025 | Dupixent |
| Glaxosmithkline, LLC. | $3,087.79 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Takeda Pharmaceuticals U.S.A., INC. | $2,767.35 | 2019-2025 | Cuvitru, Takhzyro, Hyqvia |
| Amgen INC. | $1,761.46 | 2019-2025 | Tezspire, Otezla, Actimmune |
| Csl Behring | $1,507.25 | 2019-2025 | Haegarda, Hizentra, Andembry |
| Pharming Healthcare, INC. | $1,388.87 | 2019-2025 | Ruconest, Joenja |
| Biocryst US Sales Co., LLC | $1,337.75 | 2021-2025 | Orladeyo |
| Genzyme Corporation | $1,068.58 | 2019-2025 | |
| Grifols USA, LLC | $899.70 | 2019-2025 | Prolastin-C Liquid, Xembify, Gamunex-C |
| Kaleo, INC. | $715.07 | 2019-2024 | Auvi-Q |
| Regeneron Pharmaceuticals, INC. | $609.49 | 2024-2025 | Dupixent |
| Abbvie INC. | $583.69 | 2021-2025 | Qulipta, Rinvoq |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $525.11 | 2019-2025 | |
| Optinose US, INC. | $402.01 | 2019-2025 | |
| Alk-Abello, INC | $377.32 | 2019-2023 | Standardized Mite D. Farinae, Timothy, Standardized, Alternaria Tenuis |
| Blueprint Medicines Corporation | $365.28 | 2021-2024 | Ayvakit |
| Octapharma USA, INC. | $363.15 | 2020-2024 | Cutaquig |
| Lilly USA, LLC | $341.16 | 2019-2025 | Ebglyss |
| Leo Pharma INC. | $306.37 | 2022-2025 | Adbry, Anzupgo |
| Ars Pharmaceuticals Operations, INC. | $259.40 | 2025 | Neffy |
| Upsher-Smith Laboratories LLC | $250.16 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $235.98 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $231.83 | 2019-2025 | |
| Shire North American Group INC | $220.67 | 2019 | |
| Kedrion Biopharma, INC. | $198.37 | 2024-2025 | Rhogam Ultra-Filtered Plus, Albuked, Kedrab |
| Arcutis Biotherapeutics, INC. | $176.50 | 2025 | Zoryve |
| Adma Biomanufacturing LLC | $147.14 | 2020-2025 | |
| Horizon Therapeutics Plc | $112.64 | 2021-2023 | Actimmune |
| Boehringer Ingelheim Pharmaceuticals, INC. | $103.49 | 2021-2023 | Spiriva Respimat |
| Bio Products Laboratory USA, INC. | $101.22 | 2022-2023 | Coagadex, Gammaplex |
| Intuitive Surgical, INC. | $82.05 | 2024 | |
| Organon LLC | $70.34 | 2025 | Vtama |
| Incyte Corporation | $64.28 | 2024-2025 | Opzelura |
| Biohaven Pharmaceuticals, INC. | $57.96 | 2020-2021 | |
| Hikma Pharmaceuticals USA | $38.38 | 2023 | Ryaltris |
| Genentech, INC. | $38.00 | 2019 | |
| Merck Sharp & Dohme LLC | $34.15 | 2019-2023 | |
| Ionis Pharmaceuticals, INC. | $28.53 | 2025 | Dawnzera |
| Allergan, INC. | $26.49 | 2020 | |
| Paratek Pharmaceuticals, INC. | $25.20 | 2025 | Xhance |
| Cycle Pharmaceuticals INC | $20.80 | 2024-2025 | Sajazir |
| Biocryst Pharmaceuticals, INC. | $18.80 | 2020 | |
| Nestle Healthcare Nutrition INC. | $18.06 | 2023 | |
| Azurity Pharmaceuticals, INC. | $15.45 | 2025 | Alvesco |
| Ethicon US, LLC | $14.51 | 2019 | |
| Currax Pharmaceuticals LLC | $14.34 | 2021 | |
| Circassia INC. | $11.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Bellak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.